Artiva Biotherapeutics (ARTV) Stock Chart & Stock Price History $3.17 -0.10 (-2.94%) As of 03:47 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Artiva Biotherapeutics Stock Price Performance The Artiva Biotherapeutics (ARTV) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 70.96%, with a year-to-date return of -68.51%. In the past month, the stock has increased 7.23%, reflecting recent market activity. As of the latest close, Artiva Biotherapeutics traded at $3.27 with a market cap of $79.89 million and volume of 139,437 shares. Receive ARTV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Artiva Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+10.21%1 Month Performance+7.23%3 Month Performance+65.31%Year-To-Date Performance-68.51%1 Year Performance-70.96% ARTV Stock Chart for Thursday, August, 28, 2025 ARTV Chart by TradingView Artiva Biotherapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/27/2025$2.84$3.27+15.14%$3.39$2.78139,437 shs$79.89 million08/26/2025$2.82$2.84+0.71%$2.92$2.6837,015 shs$69.38 million08/25/2025$2.88$2.82-2.08%$2.96$2.8023,227 shs$68.88 million08/22/2025$2.77$2.88+3.97%$2.98$2.7850,086 shs$70.35 million08/21/2025$2.71$2.77+2.21%$2.90$2.6829,248 shs$67.67 million08/20/2025$2.79$2.71-2.87%$2.90$2.6424,164 shs$66.21 million08/19/2025$3.10$2.79-10.00%$3.22$2.77102,024 shs$68.15 million08/18/2025$2.75$3.10+12.73%$3.24$2.72137,354 shs$75.73 million08/15/2025$2.70$2.75+1.85%$2.81$2.6163,528 shs$67.18 million08/14/2025$2.67$2.70+1.12%$2.75$2.5636,014 shs$65.96 million Get the Latest News and Ratings for ARTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Artiva Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/13/2025$2.47$2.67+8.10%$2.69$2.4859,873 shs$65.22 million08/12/2025$2.56$2.47-3.52%$2.67$2.46112,569 shs$60.34 million08/11/2025$2.76$2.56-7.25%$2.75$2.5151,648 shs$62.54 million08/08/2025$2.64$2.76+4.55%$2.99$2.6372,275 shs$67.23 million08/07/2025$2.87$2.64-8.01%$2.92$2.6356,966 shs$64.32 million08/06/2025$3.08$2.87-6.82%$3.08$2.8476,759 shs$69.91 million08/05/2025$3.01$3.08+2.33%$3.09$2.9334,682 shs$75.03 million08/04/2025$2.83$3.01+6.36%$3.15$2.7795,297 shs$73.33 million08/01/2025$3.00$2.83-5.67%$2.95$2.7486,600 shs$68.95 million07/31/2025$2.98$3.00+0.67%$3.02$2.9169,721 shs$73.08 million07/30/2025$2.91$2.98+2.41%$3.15$2.86205,555 shs$72.59 million07/29/2025$2.96$2.91-1.69%$3.17$2.89153,551 shs$70.89 million07/28/2025$3.60$2.96-17.78%$3.66$2.92355,069 shs$72.11 million Related Companies ANNX Stock Price Chart NMRA Stock Price Chart VOR Stock Price Chart ALMS Stock Price Chart IMMP Stock Price Chart TKNO Stock Price Chart SCPH Stock Price Chart ALLO Stock Price Chart SGMT Stock Price Chart SOPH Stock Price Chart Receive ARTV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Artiva Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ARTV) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artiva Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artiva Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access